The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department ...
For U.S. publicly traded companies weighing the future of their diversity, equity and inclusion programs in the wake of President Donald Trump’s executive order gutting affirmative action measures, ...
Results that may be inaccessible to you are currently showing.